Method for assaying glycated protein

• US 7,070,948 B1
• Filed: 09/29/2000
• Issued: 07/04/2006
• Est. Priority Date: 10/01/1999
• Status: Expired due to Term

• Current Assignee: Kikkoman Corporation
• Original Assignee: Kikkoman Corporation
• Inventors: Arai, Ayumi, Koyama, Yasuji, Kajiyama, Naoki, Sakaue, Ryoichi
• Primary Examiner(s): WOOD, AMANDA P
• Application Number:
  US10/088,524
• Time in Patent Office: 2,104 Days
• Field of Search: 435/23, 435/24, 435/975
• US Class Current: 435/23
• CPC Class Codes: C12Q 1/26 involving oxidoreductase
• CPC Class Codes: C12Q 1/37 involving peptidase or proteinase
• CPC Class Codes: G01N 30/02 Column chromatography
• CPC Class Codes: Y10S 435/975 Kit

Abstract

Based on a principle that is different to that of a conventional enzymatic method, the present invention provides a novel method for assaying a glycated protein by a simple procedure, within a short period of time, and with high accuracy, and a reagent kit for assaying used in the method. The method for assaying a glycated protein in a sample is realized by treating a glycated protein-containing sample with protease to liberate a glycated peptide, preferably an α-glycated peptide, particularly preferably an α-glycated dipeptide, from a glycated protein, allowing an oxidase to react with the liberated glycated peptide, and determining the produced hydrogen peroxide.

Claims

1. A method for assaying the presence and/or amount of an alpha glycated peptide in a sample comprising:

treating a sample suspected of containing an α

-glycated peptide with at least one oxidase which produces hydrogen peroxide upon reacting with the α

-glycated peptide, and

determining the presence and/or amount of a generated product or consumed substance by said reaction.

2. The method of claim 1, comprising determining the presence and/or amount of hydrogen peroxide generated by treatment of the sample suspected of containing an α

-glycated peptide with said at least one oxidase.

3. The method of claim 2, wherein the present and/or amount of hydrogen peroxide generated by treatment of the sample suspected of containing an α

-glycated peptide with said at least one oxidase is determined using an oxygen electrode.

4. The method of claim 2, wherein the presence and/or amount of hydrogen peroxide generated by treatment of the sample suspected of containing an α

-glycated peptide with said at least one oxidase is determined enzymatically.

5. The method of claim 1, wherein said at least one oxidase is derived from a modified Corynebacterium amino acid oxidase gene.

6. The method of claim 1, wherein said at least one oxidase is the same as that produced by Escherichia coli DH5α

(pFP1).

7. The method of claim 1, wherein said glycated peptide is an α

-glycated dipeptide.

8. The method of claim 1, wherein a peptide portion of the α

-glycated peptide is a short chain peptide having 2 to 6 amino acids.

9. The method of claim 1, wherein the α

-glycated peptide is fructosyl valyl histidine.

10. The method of claim 1, further comprising treating a sample suspected of containing a glycated protein with at least one protease for a time and under conditions suitable for the production of an α

-glycated peptide to obtain said sample suspected of containing an α

-glycated peptide.

11. The method of claim 10, wherein said at least one protease is derived from Aspergillus.

12. The method of claim 10, wherein said at least one protease is derived from the genus Aspergillus and is selected from the group consisting of Molsin, AO Protease and Peptidase.

13. The method of claim 10, wherein said at least one protease is derived from Saccharomyces.

14. The method of claim 10, wherein said at least one protease is carboxypeptidase Y.

15. The method of claim 10, wherein said at least one protease is derived from Bacillus.

16. The method of claim 10, wherein said at least one protease is Protin P.

17. The method of claim 10, wherein said sample suspected of containing a glycated protein is suspected of containing HbAlc.

18. The method of claim 10, wherein said sample suspected of containing a glycated protein is suspected of containing a glycated protein other than HbAlc.

19. The method of claim 10, wherein said sample is obtained from a subject suspected of having a diabetic condition or who has a diabetic condition.

20. The method of claim 10, wherein said sample is obtained from a subject who does not have a diabetic condition.

21. A method for assaying the presence and/or amount of a glycated protein in a sample comprising:

treating a sample suspected of containing a glycated protein with at least one protease and

determining the presence or absence of, and/or amount of, fructosyl valyl histidine liberated from said sample.

22. The method of claim 21, wherein the presence or absence of, or the amount of, fructosyl valyl histidine liberated from said sample is determined by HPLC.

23. A kit comprising:

an oxidase which produces hydrogen peroxide by reacting with an α

-glycated peptide.

24. The kit of claim 23, wherein said oxidase is an oxidase derived from a modified Corynebacterium fructosyl amino acid oxidase gene.

25. The kit of claim 23, wherein said oxidase is the same as that produced by Escherichia coli DH5α

(pFP1).

26. The kit of claim 23, further comprising one or more protease(s).

27. The kit of claim 23, further comprising at least one reagent for assaying hydrogen peroxide.

28. The kit of claim 23, further comprising a nonglycated hemoglobin fraction and/or a glycated hemoglobin (HbAlc) fraction.